CAMBRIDGE, MA, May 15, 2003 -- Body1, Inc. and Boston Scientific Corporation (NYSE: "BSX") announced the launch of http://www.Reflux1.com. Reflux1 is a knowledge community, or "KnowCo", site for patients suffering from gastroesophageal reflux disease (GERD) and severe heartburn. There are approximately 15 million patients in the US alone who suffer from GERD, heartburn, or acid reflux. The launch of http://www.Reflux1.com provides these patients and their families with a comprehensive knowledge resource to address their information needs.
This alliance also creates an independent, Internet-based channel that Boston Scientific is supporting in order to provide educational information about new medical technologies for treating chronic gastric reflux and heartburn. This educational program highlights Boston Scientific's recent advances with Enteryx®, an endoscopic, injectable treatment for GERD symptoms in patients responding to and requiring daily pharmacological therapy with proton pump inhibitors.
"With The Enteryx Procedure, physicians can offer their patients a treatment that has been shown to reduce drug dependency and improve quality of life," said Michael Phalen, President of the Endoscopy business of Boston Scientific. "We are delighted to work with such an important leader in medical technologies for patient care as Boston Scientific", said Chris Messina, CEO of Body1, Inc. "We believe that they have all the ingredients for advancing the state of the art in patient care- the vision, the people, and the products".
About Body1, Inc.
Founded in February 1999, Body1, Inc. educates targeted populations on behalf of medical product manufacturers through its network of knowledge communities, or "KnowCo's" such as http://www.Heart1.com, http://www.Back1.com, and http://www.Knee1.com. In addition to patient education, Body1 provides interactive, knowledge-based tools for online medical education programs (the eForums suite). It also provides accredited physicians with complementary websites through http://www.Doctors1.org. Body1's programs all accelerate the adoption of novel approaches that enhance human health. The Body1 Network is one of the most visited online health networks with over 3 million visits per year and is accredited by the Health on the Net (HON) Foundation.
Contact: Kelly Schrade (kschrade@body1.com) 617-576-9400
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
This press release contains forward-looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, the Company's overall business strategy and other factors described in the Company's filings with the Securities and Exchange Commission.
CONTACT: Milan Kofol (508-650-8569)
Investor Relations
Boston Scientific Corporation
Paul Donovan (508-650-8541)
Media Relations
Boston Scientific Corporation
